Lv55
1160 积分 2023-12-04 加入
Inhibition of KIT for chronic urticaria: a status update on drugs in early clinical development
3天前
已完结
Revisiting the role of mast cells in autoimmunity
3天前
已完结
Mast cells in allergy and beyond
3天前
已完结
Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors
3天前
已完结
Biologics for the Use in Chronic Spontaneous Urticaria: When and Which
3天前
已完结
Emerging treatments for chronic urticaria
3天前
已完结
Unraveling the Engagement of Kinases to CRBN Through a Shared Structural Motif to Optimize PROTACs Efficacy
25天前
已完结
Finding a needle in the haystack: ADME and pharmacokinetics/pharmacodynamics characterization and optimization toward orally available bifunctional protein degraders
1个月前
已完结
Pharmacokinetic Assessment of Cooperative Efflux of the Multitargeted Kinase Inhibitor Ponatinib Across the Blood-Brain Barrier
1个月前
已完结
Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1+ acute lymphoblastic leukemia
1个月前
已完结
小干扰RNA药物在慢性病领域的研究新进展：从临床前到临床
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC
皖公网安备34019202002308
